A recently completed National Institutes of Health-funded trial confirms the efficacy of blood flow measurement technology from VasSol Inc. to predict the possibility of repeated stroke in at-risk individuals.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now